All Years | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007
2023 — 19 Books and Research Papers Citing DrugPatentWatch
Ledley, F.D., & Cleary, E.G. (2023). NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole. PLoS One.
This study examines how NIH-funded patents have extended market exclusivity for drugs approved between 2010 and 2019. It discusses the implications of the Bayh-Dole Act on public interest protections and the commercialization of federally funded research. DrugPatentWatch was cited for its data on patent expirations and market exclusivity periods, providing a foundation for the analysis.
Ledley, F.D., & Chaves da Silva, P.D. (2023). Comments Re: Workshop on Transforming Discoveries into Products: Maximizing NIH's Levers to Catalyze Technology Transfer. Bentley University Scholars.
This commentary discusses strategies to enhance the translation of NIH-funded discoveries into marketable products. It emphasizes the importance of effective technology transfer mechanisms and the role of public-private partnerships. DrugPatentWatch was referenced for its data on patent expirations and market exclusivity periods, providing a foundation for the analysis.
Response to Department of Commerce, National Institute of Standards and Technology, Agency Information Collection Activities
FD Ledley - 2023 - scholars.bentley.edu
de Almeida, T.D.M.E., Paes, T., & Cordeiro, D. (2023). The Relevance of Regional Specificities of Intellectual Property Regulations for Pharmaceutical Industries: Brazilian Law Changes That Immediately Affected Crucial Drug Patents. Medical Research.
This article explores recent changes in Brazilian intellectual property laws and their immediate impact on key pharmaceutical patents. It provides insights into how regional regulatory shifts can alter patent strategies and market exclusivity, offering a case study relevant to global patent analysis and strategic planning in the pharmaceutical industry.
Wang, L.X. (2023). A Cost-Benefit Analysis of the Medicines Patent Pool. Economics Bulletin.
Wang conducts an economic evaluation of the Medicines Patent Pool, assessing its effectiveness in balancing access to medicines with incentives for innovation. The analysis provides a framework for understanding the economic implications of patent pooling initiatives and their role in global drug accessibility.
Wang, L.X., & Zahur, N.B. (2023). Procurement institutions and essential drug supply in low and middle-income countries. ZBW – Leibniz Information Centre for Economics.
This paper examines the role of procurement institutions in ensuring the supply of essential drugs in low and middle-income countries. It discusses how procurement strategies intersect with patent considerations, affecting drug availability and pricing in these regions.
Duan, C. (2023). Mandatory Infringement. Florida Law Review.
Duan analyzes the concept of mandatory infringement in the context of pharmaceutical patents, discussing its implications for patent enforcement and market competition. The paper provides legal insights into how patent laws can be structured to balance innovation incentives with public access to medicines.
Smith, S.J.S. (2023). Public money, public goods? The Bayh Dole Act and its “manufactured substantially” provision. University of Bergen Repository.
This research delves into the 'manufactured substantially' provision of the Bayh-Dole Act, examining its impact on the commercialization of federally funded inventions. It highlights how this provision can influence patent ownership and the global distribution of patented drugs.
Bibi, S., Hasan, M.M., Hossain, M.S., & Khan, M.S. (2023). Computer-aided drug design-based system pharmacology applications for the treatment of diabetes mellitus. Approaches in Drug Design & Discovery.
The authors present a computer-aided drug design approach integrated with system pharmacology to identify potential treatments for diabetes mellitus. The study underscores the role of computational tools in accelerating drug development and optimizing patent strategies for new therapeutic agents.
Allen, L.A., Lowe, E.F., & Matlock, D.D. (2023). The Economic Burden of Heart Failure with Reduced Ejection Fraction: Living Longer but Poorer? Cardiology Clinics.
This article assesses the economic impact of heart failure with reduced ejection fraction, discussing treatment costs and the financial strain on healthcare systems. It provides context for evaluating the cost-effectiveness of patented therapies in managing chronic conditions.
de Pablo, E., O'Connell, P., Fernández-García, R., et al. (2023). Targeting lung macrophages for fungal and parasitic pulmonary infections with innovative amphotericin B dry powder inhalers. International Journal of Pharmaceutics.
The study explores the development of dry powder inhalers for delivering amphotericin B to target lung macrophages in treating pulmonary infections. It discusses the patenting of novel drug delivery systems and their potential to extend market exclusivity for existing antifungal agents.
Santos, C., & Freire, H. (2023). Do financial literacy and entrepreneurial skills lead to improved performance? Evidence from Swiss Biotechnology sector. Journal of Commercial Biotechnology.
This research investigates the relationship between financial literacy, entrepreneurial skills, and performance in the Swiss biotechnology sector. It highlights how these factors can influence strategic decisions related to patenting and commercialization of biotechnological innovations.
Plemmons, D., Sneed, K.B., & Pathak, Y. (2023). Nano therapy Spotlight: Arestin™ Minocycline Microspheres. Chem Pharm Res.
The authors focus on the development of Arestin™ minocycline microspheres as a targeted therapy for periodontal disease. The paper discusses the patenting of nanotechnology-based drug delivery systems and their implications for market exclusivity in specialized therapeutic areas.
Polat, S., Trif, M., Rusu, A., Šimat, V., & Čagalj, M. (2023). Recent advances in industrial applications of seaweeds. Critical Reviews in Food Science and Nutrition.
This review examines the industrial applications of seaweeds, including their use in pharmaceutical formulations. It touches upon the patenting of natural product-based drugs and the challenges in protecting intellectual property derived from marine resources.
Willis, M., Neslusan, C., & Nilsson, A. (2023). The Importance of Considering Price Metrics and Market Dynamics in US Economic Evaluations: The Case of SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes. ISPOR.
This paper emphasizes the need to incorporate price metrics and market dynamics into economic evaluations of new drugs, using SGLT-2 inhibitors as a case study. It provides insights into how patent strategies can impact the economic assessment of pharmaceutical products.
Gabriele, L., & David, V. (2023). Linking access to finance and governance structure with financial performance of biotechnology firms: the mediation of financial literacy. Journal of Commercial Biotechnology.
The authors explore how access to finance and governance structures influence the financial performance of biotechnology firms, with financial literacy acting as a mediator. The study highlights the importance of strategic financial management in navigating patent landscapes and commercialization challenges.
Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics, E-Book: Heart failure with reduced ejection fraction, An Issue of Cardiology Clinics …
A Ghafoor - 2023 - books.google.com
Rajput, P., Pramanik, A., & Yamsani, M. (2023). Emerging role of Machine Learning in field of Pharmacology. IEEE Conference on Advanced Computing.
This paper discusses the emerging role of machine learning in pharmacology, focusing on drug discovery and development processes. It touches upon the implications of AI-driven innovations for patenting and regulatory strategies in the pharmaceutical industry.
Ivanova, E.S. (2023). Шляхи та методи забезпечення конкурентоспроможності фармацевтичної продукції АТ «Фармак» на зовнішньому ринку. Dspace ZNU.
This research explores strategies to ensure the competitiveness of AT Farmak products in foreign markets, focusing on patenting and intellectual property management. The study discusses how patent protections can enhance or hinder competitiveness. DrugPatentWatch was referenced for its data on patent expirations and market exclusivity periods, providing a foundation for the analysis.
